This podcast episode covers a range of topics, including the challenges President Biden faces at the southern border and the potential actions he may take to address the situation. It also discusses the results of the Indian elections and the implications for the country's political landscape, as well as the ongoing debate about the use of MDMA as a treatment for post-traumatic stress disorder. The episode explores the controversies surrounding the use of psychedelics in clinical trials, specifically focusing on the validity of the findings regarding MDMA therapy. Finally, the episode touches on the controversy surrounding the FDA public meeting and the commercial advertisements that are mentioned.
